Glutathione-S-transferases in lung and sputum specimens, effects of smoking and COPD severity

doi:10.1186/1465-9921-9-80

Respiratory Research
Volume 9

Viewing options:

Abstract
Full text
PDF (3.4MB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Harju T
Mazur W
Merikallio H
Soini Y
Kinnula VL

on PubMed

Harju T
Mazur W
Merikallio H
Soini Y
Kinnula VL
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Research

Glutathione-S-transferases in lung and sputum specimens, effects of smoking and COPD severity

Terttu Harju¹^,2 , Witold Mazur³ , Heta Merikallio¹^,2 , Ylermi Soini⁴^,5 and Vuokko L Kinnula³

¹Institute of Clinical Medicine, Department of Internal Medicine, Centre of Excellence in Research, P. O. Box 5000, 90014 University of Oulu, Oulu, Finland

²Department of Internal Medicine, Clinical Research Center, Oulu University Hospital, Oulu, Finland

³Department of Medicine, Division of Pulmonary Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

⁴Department of Pathology, Oulu University Hospital, Oulu, Finland

⁵Department of Clinical Pathology and Forensic Medicine, University of Kuopio, Kuopio, Finland

author email corresponding author email

Respiratory Research 2008, 9:80doi:10.1186/1465-9921-9-80


Published:	13 December 2008

Abstract

Background

Oxidative stress plays a potential role in the pathogenesis and progression of chronic obstructive pulmonary disease (COPD). Glutathione S-transferases (GSTs) detoxify toxic compounds in tobacco smoke via glutathione-dependent mechanisms. Little is known about the regulation and expression of GSTs in COPD lung and their presence in airway secretions.

Methods

GST alpha, pi and mu were investigated by immunohistochemistry in 72 lung tissue specimens and by Western analysis in total lung homogenates and induced sputum supernatants from non-smokers, smokers and patients with variable stages of COPD severity.

Results

GST alpha was expressed mainly in the airway epithelium. The percentage of GST alpha positive epithelial cells was lower in the central airways of patients with very severe (Stage IV) COPD compared to mild/moderate COPD (p = 0.02). GST alpha by Western analysis was higher in the total lung homogenates in mild/moderate COPD compared to cases of very severe disease (p < 0.001). GST pi was present in airway and alveolar epithelium as well as in alveolar macrophages. GST mu was expressed mainly in the epithelium. Both GST alpha and pi were detectable in sputum supernatants especially in patients with COPD.

Conclusion

This study indicates the presence of GST alpha and pi especially in the epithelium and sputum supernatants in mild/moderate COPD and low expression of GST alpha in the epithelium in cases of very severe COPD. The presence of GSTs in the airway secretions points to their potential protective role both as intracellular and extracellular mediators in human lung.